@beaquilter wrote "Of course we're happy about it, but now it's terminal, so it's just a matter of how long the ADT will last..."

I don't remember the specifics of your husband's diagnosis (and am not a medical professional in any case), but ADT is just the first treatment, not the last. And I forget: is he taking an ARSI like Nubeqa or Apalutamide along with the ADT? Studies like TITAN have shown that starting those at the beginning of treatment instead of waiting for ADT to fail dramatically prolongs the period of castrate sensitivity for many people with metastatic prostate cancer, to the point that TITAN never reached median overall survival (too many participants in the study group were still alive, which is a nice problem to have 🙂). Obviously, it would be a discussion with the oncologist.